Skip to main content
. 2022 Feb 13;23(4):2060. doi: 10.3390/ijms23042060

Figure 3.

Figure 3

Antiviral activity of TL and TL1 against enveloped RNA virus. Peptides were added in four different “time-of-addition” experiments and their antiviral potential has been analysed against (A) HCoV-229E; (B) HCoV-OC43; (C) SARS-CoV-2; (D) Influenza virus; (E) MeV; and (F) HPIV-3. **** p < 0.0001; *** p < 0.001; ** p < 0.01; * p < 0.1; ns: nonsignificant. – indicates the infected and not treated cells.